AzTrials
AzTrials

Exercise TrainingNCT03645772

Plyometric Exercise to Improve Rapid Force Production in Older Men

A study testing Exercise intervention in people with Exercise Training, run by KU Leuven at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Rapid force production declines as a consequence of ageing. Given the functional relevance of rapid force production, exercise interventions in older adults should aim at improving the capacity to produce force rapidly. Read more about this study

Who is it for?
Ages 65 to 80 years, men onlyHealthy volunteers can take part
Conditions the study is for
Exercise Training
What is being tested?
Exercise intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteBelgium
Study dates
29 Jan 2018to 19 Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 80 years
  • Men only
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • -

Who cannot join

  • No systematic engagement in (resistance) exercise in the 12-months prior to participation
  • Cardiovascular disease
  • Neurological disorders
  • Cognitive malfunctioning
  • Severe knee or hip problems

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Department of Movement Sciences

    Leuven, 3001

Other trials in Belgium

About this study

Official title: Plyometric Exercise to Improve Rapid Force Production in Older Men: a Pilot Intervention

Rapid force production declines as a consequence of ageing. Given the functional relevance of rapid force production, exercise interventions in older adults should aim at improving the capacity to produce force rapidly. To improve this capacity, exercises should be performed with the intention to develop high speeds, as supported by previous work.

Human locomotion fundamentally consists of multi-joint movements and rapidly coupled eccentric-concentric muscle actions, known as stretch-shortening cycle (SSC) activities or plyometrics. Plyometrics might therefore be used to optimize power production. However, there is limited research on the feasibility of plyometrics in older adults and its potential effects on rapid force production and functional capacity. This study will test the feasibility of a 12-week plyometric exercise intervention in older men and compare its effects on rapid force production to a traditional resistance exercise or walking intervention.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03645772
Study groupRoleWhat they receive
Plyometric exerciseExperimental12-week progressive exercise program, consisting of plyometric exercises such as countermovement jump, forward and sideways step-up.
Receives: Other: Exercise intervention
Resistance exerciseActive comparator12-week resistance exercise program for the leg muscles (2-4 sets of 8-15 repetitions at 8-15RM, leg press, leg extension, calve extension).
Receives: Other: Exercise intervention
WalkingActive comparator12-week progressive walking program.
Receives: Other: Exercise intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rapid force production

    Subjects perform a test protocol on a sledge apparatus, consisting of explosive isometric voluntary contractions for the leg-extensor muscles of the right leg. The inclination of the sledge is 20° to horizontal. The seat of the sledge is inclined backwards (130°). The knee joint angle is set at 90° and the hip angle at 70°. The point of force application is aligned with the head of the fifth metatarsal. Subjects are instructed to kick as fast and as hard as possible and maintain their maximum force for approximately 3s. The rate of force development (N/s) is defined as the linear slope of the force-time curve and is measured from the onset of movement till 100 ms.

    Measured: Change from baseline in rapid force production at 12 weeks

  2. Jumping height in squat jump

    Subjects perform a test protocol on a sledge apparatus, consisting of squat jumps (SJ), countermovement jumps (CMJ), and drop jumps (DJ). The inclination of the sledge is 20° to horizontal. The seat of the sledge is inclined backwards (130°). A force platform is built in perpendicular to the jumping direction. A speed sensor is attached to the seat of the sledge, which is used to assess the transition point between braking and push-off phases and to calculate jumping height (in cm).

    Measured: Change from baseline in jumping height at 12 weeks

  3. Jumping height in countermovement jump

    Subjects perform a test protocol on a sledge apparatus, consisting of squat jumps (SJ), countermovement jumps (CMJ), and drop jumps (DJ). The inclination of the sledge is 20° to horizontal. The seat of the sledge is inclined backwards (130°). A force platform is built in perpendicular to the jumping direction. A speed sensor is attached to the seat of the sledge, which is used to assess the transition point between braking and push-off phases and to calculate jumping height (in cm).

    Measured: Change from baseline in jumping height at 12 weeks

  4. Jumping height in drop jump

    Subjects perform a test protocol on a sledge apparatus, consisting of squat jumps (SJ), countermovement jumps (CMJ), and drop jumps (DJ). The inclination of the sledge is 20° to horizontal. The seat of the sledge is inclined backwards (130°). A force platform is built in perpendicular to the jumping direction. A speed sensor is attached to the seat of the sledge, which is used to assess the transition point between braking and push-off phases and to calculate jumping height (in cm).

    Measured: Change from baseline in jumping height at 12 weeks

Secondary outcomes (8)
  1. Leg press one-repetition maximum

    Leg press one-repetition maximum is defined as the maximum weight (in kg) that the subject can push on a leg press device (Signature Series Leg press Life Fitness).

    Measured: Change from baseline in leg press 1-RM at 12 weeks

  2. Maximal isometric strength

    Maximal strength (Nm) is measured by means of unilateral isometric knee-extensor tests on a Biodex dynamometer.

    Measured: Change from baseline in maximal isometric strength at 12 weeks

  3. Maximal isokinetic strength

    Maximal strength (Nm) is measured by means of unilateral isokinetic knee-extensor tests on a Biodex dynamometer.

    Measured: Change from baseline in maximal isokinetic strength at 12 weeks

  4. Stair Climbing performance

    Stair ascent duration (in s), the time needed to ascent a flight of stairs.

    Measured: Change from baseline in Stair Climbing performance at 12 weeks

  5. Gait speed

    The average speed to walk 10m as fast as possible (in m/s).

    Measured: Change from baseline in gait speed at 12 weeks

  6. 5 repetition sit-to-stand test

    The time needed to perform 5 sit-to-stand transitions (in s).

    Measured: Change from baseline in sit-to-stand duration at 12 weeks

  7. 6 minute walk distance

    The walk distance (in m) covered in 6 min.

    Measured: Change from baseline in 6min walk distance at 12 weeks

  8. Balance

    Overall balance performance is assessed using the total length of the sway path divided by duration of the measurement (mm/s) in a 30s balance test on a balance board.

    Measured: Change from baseline in balance at 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Aug 2018
  2. Study start29 Jan 2018
  3. Primary completion19 Jun 2018
  4. Study completion19 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03645772
Sponsor's protocol ID
S60983
Status last verified
Aug 2018
First submitted
17 Aug 2018
Last updated
24 Aug 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise intervention in people with Exercise Training, run by KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rapid force production (time frame: Change from baseline in rapid force production at 12 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in